Our Team
Bill Enright
Chief Executive Officer & Board Director
William “Bill” Enright is a seasoned biotech executive with more than thirty years of experience in building and financing both privately held and publicly held companies...
Bill Enright
Chief Executive Officer & Board Director
William “Bill” Enright is a seasoned biotech executive with more than thirty years of experience in building and financing both privately held and publicly held companies...
Dr. Geoffrey Lynn
CHIEF SCIENTIFIC OFFICER
Geoffrey Lynn, MD, PhD, is an experienced innovator and biotech executive who was the primary inventor of Barinthus Bio’s SNAP technology platform and has more than 15 years of experience...
Dr. Geoffrey Lynn
CHIEF SCIENTIFIC OFFICER
Geoffrey Lynn, MD, PhD, is an experienced innovator and biotech executive who was the primary inventor of Barinthus Bio’s SNAP technology platform and has more than 15 years of experience...
Dr. Leon Hooftman
CHIEF MEDICAL OFFICER
Dr. Leon Hooftman brings significant drug development expertise across a broad array of therapeutic areas including oncology, infectious diseases, and inflammation...
Dr. Leon Hooftman
CHIEF MEDICAL OFFICER
Dr. Leon Hooftman brings significant drug development expertise across a broad array of therapeutic areas including oncology, infectious diseases, and inflammation...
Robin Wright
Chairman
Robin Wright has extensive senior level experience as a CFO of public companies in both the pharmaceutical and biotechnology industries...
Robin Wright
Chairman
Robin Wright has extensive senior level experience as a CFO of public companies in both the pharmaceutical and biotechnology industries...
Karen Dawes
Non-Executive Director
Karen Dawes has held senior executive and commercial positions at key biopharmaceutical companies and was responsible for the successful launch and marketing of a number of drugs...
Karen Dawes
Non-Executive Director
Karen Dawes has held senior executive and commercial positions at key biopharmaceutical companies and was responsible for the successful launch and marketing of a number of drugs...
Alex Hammacher
Non-Executive Director
Alex is Head of Corporate Finance at Oxford Science Enterprises (OSE) and a former physician. OSE is the £1.2bn venture capital firm partnered with Oxford University...
Alex Hammacher
Non-Executive Director
Alex is Head of Corporate Finance at Oxford Science Enterprises (OSE) and a former physician. OSE is the £1.2bn venture capital firm partnered with Oxford University...
Dr. Anne Phillips
Non-Executive Director
Dr. Phillips is the Senior Vice President, Clinical, Medical & Regulatory Affairs, North America Operations, for Novo Nordisk Inc...
Dr. Anne Phillips
Non-Executive Director
Dr. Phillips is the Senior Vice President, Clinical, Medical & Regulatory Affairs, North America Operations, for Novo Nordisk Inc...
Pierre A Morgon
Non-Executive Director
Pierre is CEO of MRGN Advisors, Regional Partner for Switzerland at Mérieux Equity Partners and Senior Vice President International Business at CanSino Biologics...
Pierre A Morgon
Non-Executive Director
Pierre is CEO of MRGN Advisors, Regional Partner for Switzerland at Mérieux Equity Partners and Senior Vice President International Business at CanSino Biologics...
Dr. Joseph Scheeren
Non-Executive Director
Joseph Scheeren has been a member of our board of directors since March 2021. Dr. Scheeren most recently served as President and Chief Executive Officer of Critical Path Institute...
Dr. Joseph Scheeren
Non-Executive Director
Joseph Scheeren has been a member of our board of directors since March 2021. Dr. Scheeren most recently served as President and Chief Executive Officer of Critical Path Institute...